Amneal Pharmaceuticals, Inc. AMRX Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Amneal Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s asset turnover?
- Amneal Pharmaceuticals, Inc. (AMRX) reported asset turnover of 0.9× in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s asset turnover changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s asset turnover increased by 6.3% year-over-year, from 0.8× to 0.9×.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s asset turnover?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s asset turnover has grown at a 10.1% compound annual growth rate (CAGR), from 0.5× to 0.8×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.